These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6148934)

  • 1. [3H]dihydroergocryptine binding to alpha-adrenoceptors in human femoral veins and arteries.
    Kaiser B; Glusa E; Hoffmann A; Markwardt F
    Biomed Biochim Acta; 1984; 43(4):439-46. PubMed ID: 6148934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha adrenergic receptors in beef aortic membranes characterised by [3H] dihydroergocryptine binding.
    Carman-Krzan M
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):237-50. PubMed ID: 6254455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
    Shi AG; Kwan CY; Daniel EE
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1119-24. PubMed ID: 2550616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]-guanfacine: a radioligand that selectively labels high affinity alpha2-adrenoceptor sites in homogenates of rat brain.
    Jarrott B; Louis WJ; Summers RJ
    Br J Pharmacol; 1982 Feb; 75(2):401-8. PubMed ID: 6138110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P; Meyer P
    Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):131-8. PubMed ID: 3014111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
    Bobik A
    Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
    Ordway GA; Jaconetta SM; Halaris AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of postjunctional alpha-adrenoceptors in isolated human femoral veins and arteries.
    Glusa E; Markwardt F
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):101-5. PubMed ID: 6136916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):195-203. PubMed ID: 2984413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y; Powell A; Arinze IJ
    J Clin Endocrinol Metab; 1986 May; 62(5):827-32. PubMed ID: 3007555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S66-75. PubMed ID: 2414598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased affinity and preference of halogenated derivatives of BE 2254 for alpha 1-adrenoceptors demonstrated by functional and binding experiments.
    Schlicker E; Brodde OE; Göthert M; Schaperdoth M
    J Cardiovasc Pharmacol; 1984; 6(6):1238-44. PubMed ID: 6084785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics of [3H]guanfacine to rat brain alpha-adrenoceptors. Comparison with [3H]clonidine.
    Timmermans PB; Schoop AM; van Zwieten PA
    Biochem Pharmacol; 1982 Mar; 31(6):899-905. PubMed ID: 6282284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA; Marks BH
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Oct; 47(4):1295-301. PubMed ID: 3018166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W; Raulf M; Otto T; Michel MC
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 adrenoceptor selectivity of phenoxybenzamine in the rat kidney.
    Smyth DD; Umemura S; Pettinger WA
    J Pharmacol Exp Ther; 1984 Aug; 230(2):387-92. PubMed ID: 6086885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.